In contrast, thymidine phosphorylase (TP) gene therapy aims to enhance the sensitivity of tumor cells to prodrugs such as 5-fluorouracil (5-FU) and 5′-deoxy-5-fluorouridine (5′-DFUR) by transfecting cancer cells with TP. This evidence concerns the gene TYMP and cancer.